Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Bile Duct Neoplasms (Phase 1/Phase 2)
Breast Neoplasms (Phase 2)
Carcinoma, Mucoepidermoid (Phase 1/Phase 2)
Carcinoma, Renal Cell (Phase 1/Phase 2)
Cholangiocarcinoma (Phase 1/Phase 2)
Colonic Neoplasms (Phase 1/Phase 2)
Colorectal Neoplasms (Phase 1/Phase 2)
Genes, erbB-2 (Phase 1/Phase 2)
Hamartoma (Phase 1/Phase 2)
Head and Neck Neoplasms (Phase 1/Phase 2)
Laryngeal Neoplasms (Phase 1/Phase 2)
Liver Neoplasms (Phase 1/Phase 2)
Lung Neoplasms (Phase 1/Phase 2)
Mouth Neoplasms (Phase 1/Phase 2)
Neoplasms (Phase 1/Phase 2)
Ovarian Neoplasms (Phase 1/Phase 2)
Pancreatic Neoplasms (Phase 1/Phase 2)
Prostatic Neoplasms (Phase 1/Phase 2)
Rare Diseases (Phase 1/Phase 2)
Rectal Neoplasms (Phase 1/Phase 2)
Salivary Gland Neoplasms (Phase 1/Phase 2)
Skin Neoplasms (Phase 1/Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 1/Phase 2)
Stomach Neoplasms (Phase 1/Phase 2)
Tongue Neoplasms (Phase 1/Phase 2)
Tonsillar Neoplasms (Phase 1/Phase 2)
Urinary Bladder Neoplasms (Phase 1/Phase 2)
Urologic Neoplasms (Phase 1/Phase 2)
Uterine Cervical Neoplasms (Phase 1/Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue